The effect of vasopressin treatment on learning in Down's syndrome

J. Eisenberg; Rahel Hamburger-Bar; R. H. Belmaker

doi:10.1007/BF01245031

The effect of vasopressin treatment on learning in Down's syndrome

J. Eisenberg
, Rahel Hamburger-Bar
, R. H. Belmaker

Research output: Contribution to journal › Article › peer-review

9 Scopus citations

Abstract

Vasopressin is reported to enhance learning and memory in animal models. In 9 Down's syndrome patients DDAVP, a vasopressin derivative, was administered for 10 days, 40 μg per day, in a double-blind randomized crossover design. A visual-verbal paired associate learning test showed a not significant tendency for benefit with DDAVP. Word List memory was not improved with DDAVP treatment.

Original language	English
Pages (from-to)	143-147
Number of pages	5
Journal	Journal of Neural Transmission
Volume	60
Issue number	2
DOIs	https://doi.org/10.1007/BF01245031
State	Published - 1 Jun 1984
Externally published	Yes

ASJC Scopus subject areas

Neurology
Clinical Neurology
Psychiatry and Mental health
Biological Psychiatry

Access to Document

10.1007/BF01245031

Cite this

@article{f30be79039f346858bea7d7dc819e765,

title = "The effect of vasopressin treatment on learning in Down's syndrome",

abstract = "Vasopressin is reported to enhance learning and memory in animal models. In 9 Down's syndrome patients DDAVP, a vasopressin derivative, was administered for 10 days, 40 μg per day, in a double-blind randomized crossover design. A visual-verbal paired associate learning test showed a not significant tendency for benefit with DDAVP. Word List memory was not improved with DDAVP treatment.",

author = "J. Eisenberg and Rahel Hamburger-Bar and Belmaker, \{R. H.\}",

year = "1984",

month = jun,

day = "1",

doi = "10.1007/BF01245031",

language = "English",

volume = "60",

pages = "143--147",

journal = "Journal of Neural Transmission",

issn = "0300-9564",

publisher = "Springer",

number = "2",

}

TY - JOUR

T1 - The effect of vasopressin treatment on learning in Down's syndrome

AU - Eisenberg, J.

AU - Hamburger-Bar, Rahel

AU - Belmaker, R. H.

PY - 1984/6/1

Y1 - 1984/6/1

N2 - Vasopressin is reported to enhance learning and memory in animal models. In 9 Down's syndrome patients DDAVP, a vasopressin derivative, was administered for 10 days, 40 μg per day, in a double-blind randomized crossover design. A visual-verbal paired associate learning test showed a not significant tendency for benefit with DDAVP. Word List memory was not improved with DDAVP treatment.

AB - Vasopressin is reported to enhance learning and memory in animal models. In 9 Down's syndrome patients DDAVP, a vasopressin derivative, was administered for 10 days, 40 μg per day, in a double-blind randomized crossover design. A visual-verbal paired associate learning test showed a not significant tendency for benefit with DDAVP. Word List memory was not improved with DDAVP treatment.

UR - https://www.scopus.com/pages/publications/0021212044

U2 - 10.1007/BF01245031

DO - 10.1007/BF01245031

M3 - Article

C2 - 6238133

AN - SCOPUS:0021212044

SN - 0300-9564

VL - 60

SP - 143

EP - 147

JO - Journal of Neural Transmission

JF - Journal of Neural Transmission

IS - 2

ER -

The effect of vasopressin treatment on learning in Down's syndrome

Abstract

ASJC Scopus subject areas

Access to Document

Fingerprint

Cite this